2018, Number 1
<< Back Next >>
Rev Med Inst Mex Seguro Soc 2018; 56 (1)
Non-Hodgkin lymphoma. Incidental finding in a renal donor, 10 years after the evolution in recipient
Hernández-Rivera JCH, Pérez-López MJ, Cardona-Chavez JG, Chucuan-Castillo CA, Salazar-Mendoza M, Paniagua-Sierra J
Language: Spanish
References: 15
Page: 112-115
PDF size: 278.62 Kb.
ABSTRACT
Background: The incidence of cancer in transplant recipients is higher
than in the general population. Cutaneous and lymphoproliferative tumors
are the primary neoplasms that will develop these patients. Little is known
about the transmission of cancer in organ and tissue donation; it has
been described that neoplasms can be transmitted to immunosuppressed
patients when donor organs with neoplasms are inadvertently transplanted.
Case report: Patient of 29 years of age who underwent kidney transplantation
10 years ago. The kidney was donated by his father, who was
58 years. An incidental finding in the bench surgery showed a tumor of
about 1 cm in the donated kidney. The intraoperative histopathological
study showed no alterations, but two weeks after the surgery it was diagnosed
follicular non-Hodgkin lymphoma grade II retroperitoneal. Subsequently,
the donor underwent radiotherapy, since it was documented
local growth of lymph. The recipient was monitored, given that the complete
tumor was removed free of neoplasia in all its edges. 10 years
after the transplantation, both donor and recipient are free of neoplastic
disease and the latter has a stable renal function.
Conclusions: In the presence of an incidental neoplasm from a renal
donor, the possibility of donation must be reconsidered in the face of an
in situ neoplasm. We suggest detailed protocol prior to transplant and a
thorough exploration in the surgical event in order to detect tumors with
intraoperative study.
REFERENCES
Musquera M, Pérez M, Peri L, Esforzado N, Sabastià M, Paredes D, et al. Kidneys from donors with incidental renal tumors: should they be considered aceptable option for transplantation? Transplantation. 2013;95:1129-33.
Olsburgh J, Thomas K, Wong K, Bultitude M, Glass J, Rottenberg G, et al. Incidental renal stones in potential live kidney donors: prevalence, assessment and donation, including role of ex vivo ureteroscopy. BJU Int. 2013;111:784-92.
Nicol DL, Preston JM, Wall DR, Griffin AD, Campbell SB, Isbel NM, et al. Kidneys from patients with small renal tumours: A novel source of kidneys for transplantation. BJU Int. 2008;102:188-93.
Mannami M, Mannami R, Mitsuhata N. Last resort for renal transplant recipients, ‘restored’ kidneys from living donors/patients. Am J Transplant. 2008; 8:811-8.
Frank I, Blute M, Cheville JC. Solid renal tumors: An analysis of pathologic features related to tumor size. J Urology. 2003;170:2217-20.
Pahernick S, Ziegler S, Roos F. Small renal tumors: Correlation of clinical and pathological features with tumor size. J Urology. 2007;178:414-7.
Flechner S, Campbell S. The use of kidneys with small renal tumors for tansplantation: Who is taking the risk? Am J Transplant. 2012;12:48-54.
Xiao D, Craig J, Chapman J, Dominguez-Gil B, Tong A, Wong G. Donor cancer transmission in kidney transplantation: a systematic review. Am J Transplant. 2013;13:2645-52.
Sener A, Uberoi V, Bartlett ST, Kramer AC, Phelan MW. Living-donor renal transplantation of grafts with incidental renal masses after ex vivo partial nephrectomy. BJU Int. 2009;104:1655-60.
Cano-Muñoz I, Escobar-Prieto A, Isassi-Chapa A, Treviño M, Vázquez-Nañez J. Linfomas, nueva clasificación y tratamiento. Incidencia de las lesiones en el Hospital San José de 1990 a 2004. Correlación clínico-radiológica. Anales de Radiología México. 2006;2:117-36.
Laborda F, Lozano-Lozano D, Gil J, Serrado-Pardo R, Fernandez-Rañada J. Linfoma no Hodgkin y aparato urinario. A propósito de un caso. Actas Urol Esp. 2005;29(4):427-32.
Walker TL, Lopez GE. A Case of an Abdominal Mass: Follicular Lymphoma. Perm J. 2011;15(4):61-4.
Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin’s Lymphoma Classification Project. J Clin Oncol. 1998;16(8):2780-95.
Luminari S, Bellei M, Biasoli I, Federico M. Follicular lymphoma – treatment and prognostic factors. Rev Bras Hematol Hemoter. 2012;34(1):54-9.
Freedman A. Follicular lymphoma: 2011 update on diagnosis and management. Am J Hematol. 2011;86 (9):768-75.